TVT Registry: Favorable TAVR Outcomes in Low-risk Bicuspid Patients TVT Registry: Favorable TAVR Outcomes in Low-risk Bicuspid Patients
Results were on par with matched patients with tricuspid aortic stenosis, but experts caution that the heart team is essential for patient selection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 27, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news
Abbott Receives CE Mark for Navitor(TM), the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Latest-generation TAVI system features advancements to reduce or eliminate risk of blood leakage around valve implant
The non-surgical Navitor TAVI system offers best-in-class deliverability and access through small vessels, expanding treatment options ... Devices, Interventional, Cardiology, Regulatory Abbott, Navitor, Transcatheter, Aortic Valve, TAVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 17, 2021 Category: Pharmaceuticals Source Type: news
Abbott Receives CE Mark for Navitor ™, the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
- Latest-generation TAVI system features advancements to reduce or eliminate risk of blood leakage around valve implant (Source: Abbott.com)
Source: Abbott.com - May 17, 2021 Category: Pharmaceuticals Source Type: news
New AHA Statement on Aortic Stenosis in Chronic Kidney Disease New AHA Statement on Aortic Stenosis in Chronic Kidney Disease
Patients with chronic kidney disease and aortic stenosis have distinctive epidemiological and pathophysiological characteristics, presenting diagnostic and management challenges, a new statement says.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 13, 2021 Category: Cardiology Tags: Cardiology News Source Type: news
Medtronic Announces CE Mark of Evolut ™ PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
The system includes 4 valve sizes with an external pericardial tissue wrap that provides advanced sealing for the largest annular range (for self-expanding TAVI technology) on the market. The approval follows a recent indication expansion for the Evolut platform in Europe for patients with severe aortic stenosis who are at a low risk of surgical mortality and patients with bicuspid aortic valves who are at intermediate, high and extreme risk of surgical mortality. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 3, 2021 Category: Cardiology Source Type: news
Medtronic Announces CE Mark of Evolut(TM) PRO+ TAVI System for Treatment of Symptomatic Severe Aortic Stenosis Patients in Europe
As TAVI Patient Population Grows, PRO+ TAVI System Launches with Four Valve Sizes and Lowest Delivery Profile
DUBLIN, May 3, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today ann... Devices, Interventional, Cardiology, Regulatory Medtronic, Evolut PRO, TAVI (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 3, 2021 Category: Pharmaceuticals Source Type: news
TAVR in Low-Risk, Young Patients: Cause for Concern? TAVR in Low-Risk, Young Patients: Cause for Concern?
Should TAVR be offered to all low-risk patients with aortic stenosis regardless of age?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients
DUBLIN, Oct. 14, 2020 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in structural heart therapi... Devices, Interventional, Cardiology Medtronic, transcatheter aortic valve replacement (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 14, 2020 Category: Pharmaceuticals Source Type: news
Outcomes Worse for Deferred Aortic Valve Replacement
FRIDAY, Oct. 2, 2020 -- For patients with symptomatic severe aortic stenosis, deferred aortic valve replacement (AVR) is associated with an increased risk for hospitalization for valve-related symptoms or worsening heart failure, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 2, 2020 Category: Pharmaceuticals Source Type: news
Patients deferred for transcatheter aortic valve replacement because of COVID-19
(JAMA Network) This single-center study of 77 patients describes the outcomes of patients with symptomatic severe aortic stenosis during the COVID-19 pandemic. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news
Aortic valve replacement during COVID-19 pandemic
(JAMA Network) The outcomes associated with deferred compared with expedited aortic valve replacement in patients with severe aortic stenosis during the COVID-19 pandemic are evaluated in this observational study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 30, 2020 Category: Infectious Diseases Source Type: news
Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis
A new study explores whether it is feasible to perform TAVI in patients with aortic stenosis and probable concomitant transthyretin amyloidosis.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
What Are the Main Acyanotic Congenital Heart Diseases?
Discussion
Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here.
Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also.
Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Some Post-TAVR Arrhythmias Likely Present Pre-TAVR but Go Undetected Some Post-TAVR Arrhythmias Likely Present Pre-TAVR but Go Undetected
Prolonged pre-TAVR ECG screening in older patients with aortic stenosis reveals a high rate of arrhythmias, many of which require treatment.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 21, 2020 Category: Cardiology Tags: Cardiology News Source Type: news
Streamlined Aortic Stenosis Care During COVID-19 Streamlined Aortic Stenosis Care During COVID-19
The pandemic has forced providers to refocus on the really critical aspects of management of severe aortic stenosis. Could this minimalist approach improve resource utilization going forward?Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 17, 2020 Category: Pathology Tags: Cardiology News Source Type: news
